Impact of COVID‐19 pandemic on lung cancer treatment scheduling
The current coronavirus disease 2019 (COVID‐19) pandemic is associated with a heavy burden on the mental and physical health of patients, regional healthcare resources, and global economic activity. Many patients with lung cancer are thought to be affected by this situation. Therefore, in this study...
Main Authors: | Kohei Fujita, Takanori Ito, Zentaro Saito, Osamu Kanai, Koichi Nakatani, Tadashi Mio |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-10-01
|
Series: | Thoracic Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1111/1759-7714.13615 |
Similar Items
-
Rare case of de novo EGFR L718V mutation-positive non-small cell lung cancer successfully treated with afatinib
by: Takanori Ito, et al.
Published: (2023-06-01) -
Safety of flexible bronchoscopy and clinical course for elderly patients with suspected primary lung cancer
by: Zentaro Saito, et al.
Published: (2024-03-01) -
Effect of cyclooxygenase inhibitor use on immunotherapy efficacy in non‐small cell lung cancer
by: Osamu Kanai, et al.
Published: (2021-03-01) -
Comparison of the acceptability and safety of molnupiravir in COVID-19 patients aged over and under 80 years
by: Kohei Fujita, et al.
Published: (2023-06-01) -
Pleural involvement of diffuse large B-cell lymphoma mimicking malignant pleural mesothelioma
by: Takanori Ito, et al.
Published: (2020-01-01)